ORI
CYTK icon

Oak Ridge Investments’s Cytokinetics CYTK Stock Holding History

Oak Ridge Investments’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77M Buy
32,518
+16,616
+104% +$1.19M 0.16% 92
2026
Q1 		$1.05M Buy
15,902
+225
+1% +$14.3K 0.07% 121
2025
Q4 		$996K Sell
15,677
-389
-2% -$24.2K 0.06% 125
2025
Q3 		$883K Sell
16,066
-185
-1% -$7.62K 0.06% 127
2025
Q2 		$537K Sell
16,251
-845
-5% -$29.4K 0.04% 143
2025
Q1 		$687K Buy
17,096
+2,232
+15% +$103K 0.06% 129
2024
Q4 		$699K Sell
14,864
-2,907
-16% -$151K 0.05% 132
2024
Q3 		$938K Sell
17,771
-717
-4% -$40K 0.08% 114
2024
Q2 		$1M Buy
+18,488
New +$1.12M 0.1% 110

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oak Ridge Investments's CYTK Position: Q2 2026 in Review

Oak Ridge Investments increased its Cytokinetics (CYTK) stake by 104% in Q2 2026, buying an estimated $1.19M and bringing the position to 32,518 shares worth $2.77M. The position accounts for 0.16% of the portfolio, ranked #92.

Oak Ridge Investments first reported a position in CYTK in Q2 2024 and has held it in 9 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Oak Ridge Investments held 32,518 shares of Cytokinetics worth $2.77M as of Q2 2026.
  • Oak Ridge Investments bought 16,616 Cytokinetics shares in Q2 2026, an estimated $1.19M.
  • Cytokinetics made up 0.16% of Oak Ridge Investments's portfolio in Q2 2026, its #92 holding.
  • Oak Ridge Investments first reported a position in Cytokinetics in Q2 2024 and has held it in 9 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.